文献速递乳腺癌放疗放疗物理与技术

3,3'-二吲哚甲烷通过保护正常细胞调节抗肿瘤免疫增强放疗后肿瘤消退

3,3'-Diindolylmethane Enhances Tumor Regression After Radiation Through Protecting Normal Cells to Modulate Antitumor Immunity.
PubMed 文献 · Adv Radiat Oncol · 2020-10-24

本研究利用免疫健全与免疫缺陷小鼠肿瘤移植模型,探讨3,3'-二吲哚甲烷(DIM)联合放疗对肿瘤消退及正常细胞保护的作用。结果显示DIM仅在免疫健全小鼠中增强放疗后肿瘤消退,并增加瘤内免疫细胞、保护正常细胞免受辐射即时损伤,提示DIM通过保护正常细胞调节抗肿瘤免疫来增强放疗疗效。

要点

  • DIM联合放疗仅在免疫健全小鼠中增强肿瘤消退,免疫缺陷小鼠中无此效应。
  • DIM增加放疗后瘤内免疫细胞,促进黏附和抗原加工等免疫应答。
  • DIM在体内外保护正常细胞免受辐射诱导的即时细胞损伤。

核心结论

  • DIM保护正常细胞免受辐射即时损伤,联合放疗增强抗肿瘤免疫应答和放疗疗效。

研究设计与样本

  • 使用免疫健全和免疫缺陷小鼠品系建立肿瘤移植模型,采用屏蔽窄束辐射靶向肿瘤部位。
  • 比较DIM联合放疗与单纯放疗后的肿瘤消退,并通过免疫组化染色和基因表达谱分析评估DIM对放疗疗效的影响。
  • 通过全血细胞计数、克隆形成细胞存活实验和培养细胞全局基因表达谱分析研究DIM对正常细胞的辐射防护作用。

主要发现

  • DIM在免疫健全小鼠中增强放疗后肿瘤消退,但在免疫缺陷小鼠中无此作用。
  • DIM增加放疗后瘤内免疫细胞,促进黏附和抗原加工等免疫应答。
  • DIM在体外和体内保护正常细胞免受辐射诱导的即时损伤。
  • 培养细胞转录组分析显示DIM轻度增加某些通常由辐射诱导的基因表达,如细胞周期阻滞和凋亡相关基因。

临床怎么用

  • 临床前证据提示DIM联合放疗可能通过保护正常细胞和增强抗肿瘤免疫来提高疗效,但尚未在临床中验证。

局限性

  • 研究为临床前培养细胞和乳腺癌模型,结论尚未在人体中证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Preclinical and clinical data indicate that radiation therapy acts as an immune modifier, having both immune-stimulatory and immunosuppressive effects on the tumor-immune microenvironment (TIME). 3.3'-diindolylmethane (DIM) sensitizes tumor cells to radiation and protects mice from lethal doses of total body irradiation. We hypothesize that protecting nontumoral cells from the adverse effects of radiation treatment (RT) may help to correct immunosuppression resulting from radiation. METHODS AND MATERIALS: We generated tumor graft models using immune-competent and immune-deficient mouse strains. Narrow-beamed radiation was targeted to tumor sites using shielding. Tumor regression was monitored after DIM and RT versus RT alone. The effects of DIM on the efficacy of RT were assessed using immunohistochemistry staining and gene expression profiling. Complete blood counts, clonogenic cell survival assays, and global gene expression profiling of cultured cells were performed to study DIM's radioprotective effects on normal cells. RESULTS: DIM enhanced tumor regression after RT in immune-competent but not immune-deficient mice. Data indicated that DIM increased intratumoral immune cells after RT, contributing to enhanced immunologic responses such as adhesion and antigen processing. DIM protected normal cells from radiation-induced immediate injuries in vitro and in vivo. Transcriptomic profiling of cultured cells showed that DIM treatment mildly increased expression of some genes that are normally induced after radiation, such as genes involved in cell cycle arrest and apoptosis. CONCLUSIONS: In this study, using cultured cells and preclinical breast cancer models, we show that DIM protects normal cells from radiation-induced immediate cellular injury and combination treatment of DIM and radiation potentiates antitumor immune responses and enhances the efficacy of RT.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Li L, Chen R, Lin YT, et al. 3,3'-Diindolylmethane Enhances Tumor Regression After Radiation Through Protecting Normal Cells to Modulate Antitumor Immunity. Adv Radiat Oncol. 2020. PMID: 33490731. doi:10.1016/j.adro.2020.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。